Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07102823

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Graz, Graz, Austria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clinical diagnosis of COPD
  • right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output)
  • age >= 18 years

Exclusion criteria

  • pediatric patients
  • no COPD or no RHC

Treatment and study plan

Primary outcomes

  1. Severe Pulmonary Hypertension (PH)

    Time frame: at inclusion

    pulmonary vascular resistance > 5 WU (Wood Units)

  2. all-cause mortality

    Time frame: Until 2026

    all-cause mortality

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Official study title

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis

Acronym: COPD-PH

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Aug 5, 2025
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.